ORIC Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| PFIZER INC | 02/14/2025 | 5.38 M | $43.39 M | 100.00% | 7.62% |
| NEXTECH INVEST LTD. | 02/14/2025 | 5.29 M | $42.66 M | 0.00% | 7.49% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 5.11 M | $41.26 M | 0.22% | 7.25% |
| VIKING GLOBAL INVESTORS LP | 02/14/2025 | 4.43 M | $35.76 M | 10.78% | 6.28% |
| VR ADVISER, LLC | 02/14/2025 | 4.39 M | $35.46 M | 0.00% | 6.23% |
| ALKEON CAPITAL MANAGEMENT LLC | 02/14/2025 | 3.90 M | $31.51 M | 0.00% | 5.53% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 3.89 M | $31.38 M | -6.15% | 5.51% |
| COLUMN GROUP LLC | 02/14/2025 | 3.54 M | $28.57 M | 0.00% | 5.02% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 3.42 M | $27.58 M | 0.00% | 4.85% |
| VANGUARD GROUP INC | 02/11/2025 | 3.20 M | $25.85 M | 1.15% | 4.54% |
| FMR LLC | 02/13/2025 | 2.47 M | $19.92 M | -43.64% | 3.50% |
| COMMODORE CAPITAL LP | 02/14/2025 | 2.00 M | $16.14 M | 0.00% | 2.84% |
| 02/14/2025 | 1.73 M | $13.98 M | 100.00% | 2.46% | |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 1.58 M | $12.76 M | 66.48% | 2.24% |
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 1.57 M | $12.64 M | 4.41% | 2.22% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 1.56 M | $12.55 M | 37.50% | 2.20% |
| FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 1.45 M | $11.71 M | 0.00% | 2.06% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 1.40 M | $11.26 M | 3.02% | 1.98% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.30 M | $10.45 M | 16.16% | 1.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.28 M | $10.32 M | 0.41% | 1.81% |
| VIVO CAPITAL, LLC | 02/13/2025 | 1.28 M | $10.31 M | 0.00% | 1.81% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 1.27 M | $10.21 M | -12.57% | 1.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 1.18 M | $9.51 M | 7.17% | 1.67% |
| SIREN, L.L.C. | 02/14/2025 | 1.01 M | $8.13 M | 0.00% | 1.43% |
| EUCLIDEAN CAPITAL LLC | 02/14/2025 | 989,410 | $7.98 M | 0.00% | 1.40% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 950,522 | $7.67 M | 0.01% | 1.35% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 724,319 | $5.85 M | 100.00% | 1.03% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 717,188 | $5.79 M | 16.82% | 1.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 500,000 | $4.04 M | -13.04% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 417,955 | $3.37 M | 1.88% | 0.59% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 355,000 | $2.86 M | 0.00% | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 273,213 | $2.20 M | 112.79% | 0.39% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 270,006 | $2.18 M | -16.31% | 0.38% |
| FRED ALGER MANAGEMENT, LLC | 02/14/2025 | 219,276 | $1.77 M | -0.08% | 0.31% |
| 02/14/2025 | 214,291 | $1.73 M | 100.00% | 0.30% | |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 200,000 | $1.61 M | 100.00% | 0.28% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 186,430 | $1.50 M | 6.91% | 0.26% |
| UBS OCONNOR LLC | 02/14/2025 | 174,846 | $1.41 M | 22.00% | 0.25% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 167,502 | $1.35 M | 0.00% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 167,299 | $1.35 M | 0.08% | 0.24% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 01/15/2025 | 162,909 | $1.31 M | 18.08% | 0.23% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 147,800 | $1.19 M | 6.03% | 0.21% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 139,683 | $1.13 M | -24.12% | 0.20% |
| MONACO ASSET MANAGEMENT SAM | 02/10/2025 | 135,561 | $1.09 M | -9.96% | 0.19% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 135,000 | $1.09 M | 100.00% | 0.19% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 130,188 | $1.05 M | -0.35% | 0.18% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/14/2025 | 120,000 | $968,400 | 100.00% | 0.17% |
| BARCLAYS PLC | 02/13/2025 | 114,692 | $927,000 | 6.93% | 0.16% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 107,862 | $870,446 | 8.40% | 0.15% |
| M&T BANK CORP | 02/06/2025 | 99,234 | $801,073 | 16.56% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ORIC Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 146 institutional investors and hedge funds held shares of ORIC Pharmaceuticals, Inc.. The most heavily invested institutionals were:
PFIZER INC: 5.38 M
Nextech Invest Ltd.: 5.29 M
BlackRock Funding, Inc. /DE: 5.11 M
VIKING GLOBAL INVESTORS LP: 4.43 M
VR Adviser, LLC: 4.39 M
ALKEON CAPITAL MANAGEMENT LLC: 3.9 M
107.44% of ORIC Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 84.76 M shares in the last 24 months. This purchase volume represents approximately $705.17 M in transactions.